HB 305 – OhioStatus: In Process
Year Introduced: 2021
Prohibits a health plan issuer from imposing cost-sharing on a prescription insulin drug in an amount that exceeds $35 for a 30-day supply.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
No items found